A156100 logo

L&K Biomed Ltd. Stock Price

KOSDAQ:A156100 Community·₩218.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A156100 Share Price Performance

₩10,520.00
3770.00 (55.85%)
₩10,520.00
3770.00 (55.85%)
Price ₩10,520.00

A156100 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Proven track record with mediocre balance sheet.

2 Risks
1 Reward

L&K Biomed Ltd. Key Details

₩40.0b

Revenue

₩7.2b

Cost of Revenue

₩32.8b

Gross Profit

₩30.8b

Other Expenses

₩2.0b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
97.66
82.06%
5.07%
60.4%
View Full Analysis

About A156100

Founded
2008
Employees
96
CEO
Guk-jin Kang
WebsiteView website
www.lnkbiomed.com

L&K Biomed Ltd., a medical company, manufactures and sells spinal implants in South Korea, the United States, Thailand, and internationally. The company offers spinal products comprising BlueEX-T, BluEX-TC, BluEX-A, BlueEX-L, and BluEX-ATP; BluEX-LT, an advanced lateral cage system for spinal lordosis restoration; PathLoc-TM, an expandable TLIF/PLIF lumbar cage system; AccelFix-XL, an expandable lateral lumbar cage system; AccelFix-XTP, an expandable lumbar cage system for anterior-to-psoas approach; and PathLoc-TA, an expandable ALIF anterior lumbar cage system. It also provides CastleLoc-C, an anterior cervical interbody fusion cage; CastleLoc-P, an anterior cervical plate system; CastleLoc-S, a posterior cervical fixation system; AccelFix-S, a lumbar spinal fixation screw system; AccelFix-LP, a lumbar plate system; OpenLoc-L, a lumbar spinal fixation system; LnK Lumbar Peek Cages for posterior lumbar interbody fusion procedures; PathLoc-L, a MIS spinal system; AccelFix-MIS, a spinal fixation system; and PathLoc-SI sacroiliac fixation and fusion system that offers fusion and stabilization of the SI joint. In addition, the company offers CastleLoc Pectus bar system for the correction of pectus excavatum. L&K Biomed Ltd. was founded in 2008 and is headquartered in Yongin-si, South Korea.